AT273369B - Process for the production of a rubella vaccine - Google Patents

Process for the production of a rubella vaccine

Info

Publication number
AT273369B
AT273369B AT621967A AT621967A AT273369B AT 273369 B AT273369 B AT 273369B AT 621967 A AT621967 A AT 621967A AT 621967 A AT621967 A AT 621967A AT 273369 B AT273369 B AT 273369B
Authority
AT
Austria
Prior art keywords
production
rubella vaccine
rubella
vaccine
Prior art date
Application number
AT621967A
Other languages
German (de)
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Priority to AT621967A priority Critical patent/AT273369B/en
Application granted granted Critical
Publication of AT273369B publication Critical patent/AT273369B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
AT621967A 1967-07-04 1967-07-04 Process for the production of a rubella vaccine AT273369B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AT621967A AT273369B (en) 1967-07-04 1967-07-04 Process for the production of a rubella vaccine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT621967A AT273369B (en) 1967-07-04 1967-07-04 Process for the production of a rubella vaccine

Publications (1)

Publication Number Publication Date
AT273369B true AT273369B (en) 1969-08-11

Family

ID=3584081

Family Applications (1)

Application Number Title Priority Date Filing Date
AT621967A AT273369B (en) 1967-07-04 1967-07-04 Process for the production of a rubella vaccine

Country Status (1)

Country Link
AT (1) AT273369B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2129777A1 (en) * 1971-06-16 1972-12-21 Takeda Chemical Industries Ltd Rubella vaccine - highly attenuated live form, free from side effects

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2129777A1 (en) * 1971-06-16 1972-12-21 Takeda Chemical Industries Ltd Rubella vaccine - highly attenuated live form, free from side effects

Similar Documents

Publication Publication Date Title
CH498825A (en) Process for the production of 2-C-methyl-nucleosides
AT306765B (en) Process for the production of ferrovanadine
AT291926B (en) Process for the preparation of a binder suspension
CH467850A (en) Process for the production of a fluidizable polyepoxide preparation
AT282822B (en) Process for the production of adsorbed vaccines
AT270874B (en) Process for the production of a dentifrice
AT290265B (en) Process for the production of a laminated core
AT282824B (en) Process for the preparation of a new adjuvant vaccine
CH507326A (en) Process for the production of poly-e-caproamid
AT284605B (en) Process for the preparation of a gelling aid
CH502278A (en) Process for the production of a glass ceramic
AT290960B (en) Process for the production of a plastic spread
AT282821B (en) Process for the production of an antigen-free vaccine
AT281934B (en) Process for the production of a phosphor
CH503710A (en) Process for the production of thionocarbamates
CH504395A (en) Process for the preparation of a hydroxyindane compound
AT290610B (en) Process for the production of a concrete lining
CH526494A (en) Process for the production of methyl isobutyl ketone
AT265517B (en) Process for the production of a vaccine against distemper
AT277460B (en) Method for producing a tetanus vaccine
AT286497B (en) Process for the production of a vaccine
AT273369B (en) Process for the production of a rubella vaccine
AT281141B (en) Process for the production of a phosphor
AT281280B (en) Process for producing a measles vaccine
AT279038B (en) Process for the preparation of a vaccine against rubella